NeuPath Health Documents
Documents
0
Ticker
NPTH.V
ISIN
CA64133P1009
NeuPath Health SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
NeuPath Health Documents 2026
This page contains all official documents and SEC filings for NeuPath Health stock (NPTH.V, ISIN: CA64133P1009). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of NeuPath Health's regulatory filings.
NeuPath Health Stock analysis
NeuPath Health NeuPath Health, Inc. generates revenue through chronic pain management services provided at its clinics in Ontario and Alberta, offering comprehensive assessments and rehabilitation for chronic pain, musculoskeletal/back injuries, sports injuries, and concussions. The company serves employers and disability insurers with workplace health services and independent medical assessments via a national network of healthcare providers. Additionally, NeuPath provides contract research services to pharmaceutical and biotechnology companies. Its healthcare providers include physiatrists, neurologists, anesthesiologists, general practitioners with specialized pain training, medication management physicians, athletic therapists, and nurses. The primary buyers of NeuPath's services are employers and disability insurers seeking workplace health solutions and independent medical evaluations. Pharmaceutical and biotechnology companies contract NeuPath for research services. The company's clinic services target patients with chronic pain conditions, while its research division serves the pharmaceutical industry. NeuPath's network spans Ontario and Alberta, with a focus on specialized medical expertise across multiple disciplines. NeuPath Health, Inc. operates a network of medical clinics delivering chronic pain management and rehabilitation services. Its national provider network supports workplace health and independent medical assessments for employers and disability insurers. The firm's contract research division works with pharmaceutical and biotechnology companies, leveraging its medical expertise in pain management and rehabilitation. The company's service mix combines direct patient care with specialized industry contracts, creating multiple revenue streams from healthcare providers and corporate clients.